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Variance in IQ is associated with a wide range of health outcomes, and 1% of the 
population are affected by intellectual disability. Despite a century of research, the 
fundamental neural underpinnings of intelligence remain unclear. We integrate 
results from genome-wide association studies (GWAS) of intelligence with brain 
tissue and single cell gene expression data to identify tissues and cell types 
associated with intelligence. GWAS data for IQ (N = 78 308) were meta-analyzed 
with a study comparing 1 247 individuals with mean IQ ~170 to 8 185 controls. 
Genes associated with intelligence implicate pyramidal neurons of the 
somatosensory cortex and CA1 region of the hippocampus, and midbrain embryonic 
GABAergic neurons. Tissue-specific analyses find the most significant enrichment 
for frontal cortex brain expressed genes. These results suggest specific neuronal cell 
types and genes may be involved in intelligence and provide new hypotheses for 





 Genome-wide association studies (GWAS) have successfully identified 
statistical associations with a wide range of behavioral phenotypes and 
neuropsychiatric disorders 1–3. Increasing sample sizes has begun to yield findings 
for intelligence 4–6. The largest and most recent study of intelligence reported 18 loci 
significantly associated with intelligence 4. Significant genetic correlations were 
observed between intelligence and a variety of behavioral (educational attainment, 
smoking behaviors), anthropometric (cranial morphology, height, body composition), 
and psychiatric phenotypes (schizophrenia, autism, depressive symptoms), mirroring 
epidemiological evidence for correlations between intelligence and a broad range of 
health-related outcomes 4, 7. 
Considered alone, not all associations identified by GWAS precisely localize 
biological mechanisms amenable to subsequent experimentation. For instance, the 
most associated variant in a significant locus may not be the causal variant 8, 9, there 
may be multiple causal variants in a locus 10, loci may act through altering the 
expression of distant genes 11, and the associations identified by GWAS of complex 
traits are often spread across the genome 12–14. To extract meaningful biological 
inferences from GWAS results, it is necessary to integrate data from other sources, 
such as studies of gene expression 15. Results from gene-wise analyses in Sniekers 
et al. (2017) identified expression predominant in the brain for 14 of the 44 genes 
with significant association, although some transcription was inferred for most genes 
across most tissues 4. Integration of genomic results with data on biological 
pathways suggested that the most common function of genes associated with 
intelligence was in the development of the nervous system.  
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In silico functional annotation of GWAS results is dependent on high-quality 
biological reference data. Recently, data from the Karolinska Institutet (KI) mouse 
superset of single-cell RNA sequencing (scRNAseq) of ~10 000 single cells from 
multiple brain regions was used to map schizophrenia GWAS results to brain cell 
types 16. Genes that previously showed association with schizophrenia were 
expressed with higher specificity in pyramidal cells, medium spiny neurons, and 
interneurons than in 20 other brain cell types. This demonstrates the potential of cell-
type specific annotation to enable the construction of new functional hypotheses for 
complex traits. 
We sought to develop a better understanding of the neurobiological 
underpinnings of intelligence through combining GWAS results with a number of 
data sources concerned with tissue and cell-type specific gene expression. To this 
end, we meta-analyzed the most recent GWAS of intelligence 4 with an extreme-trait 
GWAS that compared individuals of very high intelligence to a group from the 
general population (HiQ) 17. By doing this, we increased the effective sample size of 
Sniekers et al by 25%. We then analyzed the enrichment of associations with 
intelligence in single cell expression data from the KI mouse superset (the largest 
and most comprehensive brain single-cell expression dataset available) 16, and in 
genomic and transcriptomic data from the GTEx project 18. Finally, we performed a 
novel analysis combining genomic and tissue-specific expression data with 
information from biological, disease-relevant and drug-target pathway databases to 





Materials and Methods 
 
Cohort descriptions 
Sniekers intelligence GWAS 4 
The cohort analyzed in Sniekers et al. (2017) was drawn from 7 cohorts (13 
sub-cohorts), primarily consisting of data from the UK Biobank pilot genotyping 
release (N = 54 119) and the Childhood Intelligence Consortium (N = 12 441) as well 
as five additional cohorts (N = 11 748). The phenotype for analysis was Spearman's 
g, or a primary measure of fluid intelligence that correlates highly with g 4, 19. 
Summary statistics from this analysis are available at 
https://ctg.cncr.nl/software/summary_statistics. Full details on cohort characteristics, 
genotyping and analysis are supplied in the Supplementary Material. 
 
HiQ high-intelligence GWAS 
The Duke University Talent Identification Program (TIP) cohort has been 
described previously 17. In brief, TIP is a non-profit organization that recruits and 
nurtures academically-gifted children of extremely high intelligence (top 3%) from the 
US population. For genomic study, 1 247 participants from the top 1% of TIP (top 
0.03% of population) were selected as a high-intelligence cohort (HiQ). IQ was 
inferred from performance on the Scholastic Assessment Test (SAT) or American 
College Test (ACT) taken at age 12 rather than the usual age of 18 years. A 
population comparison cohort (N = 8 185) was obtained from the The University of 
Michigan Health and Retirement Study (HRS). Participants were assumed to be 
drawn from the normal distribution of intelligence. Full details on genotyping and 





Summary statistics from Sniekers et al. (2017) and HiQ were meta-analyzed 
using METAL 4, 20. The extreme-sampling method used in TIP means the high-
intelligence individuals included in Zabaneh et al (2017) are likely to be enriched for 
variants contributing to intelligence in the population distribution 17. As such, 
standard weighting by sample size would not account for the increased discovery 
power afforded by the extreme-sampling method. Instead, analyses were weighted 
by their respective non-centrality parameters (NCP), estimated using the Genetic 
Power Calculator 21–23. Specifically, NCPs were estimated assuming a causal variant 
of 20% frequency, capturing 0.1% of variance in each phenotype, assuming HiQ 
controls are drawn from the normal distribution (+/- 2 SD from the mean) and HiQ 
cases are sampled from 4 SD above the mean, consistent with IQ > 160 in 99% of 
the cohort 17. The NCP of the Sniekers cohort (N = 78 308) was 78.4, while the NCP 
of the HiQ cohort was 21.6, suggesting the HiQ cohort contributes equivalently to a 
population cohort of ~21 000 individuals (calculated as ~1000 x NCP), increasing the 
effective sample size of Sniekers et al (2017) by 27%. Only variants present in both 
cohorts were retained for analysis.  
Following association analysis, genome-wide significant loci were defined via 
clumping in PLINK2 24. Index variants (p < 5x10-4) were merged into loci if in linkage 
disequilibrium (r2 > 0.1 within 500kb) with a variant with a lower p-value. Loci within 
50kb of each other were merged. Manhattan and QQ plots were generated using 
FUMA 25. Annotation of genomic results with: data from the EBI GWAS catalog; 
OMIM; GENCODE genes; genes previously implicated in autism and in intellectual 
disability; copy-number variants previously implicated in psychiatric disorders; and 
mouse knockout phenotypes was performed with RegionAnnotator version 1.63 
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(https://github.com/ivankosmos/RegionAnnotator). Summary statistics will be made 
available at [link available upon publication]. 
 
Heritability and partitioned heritability 
The heritability of intelligence accounted for by common variants was 
estimated using LD Score, limited to the HapMap3 variants and pre-computed LD 
scores provided with the package 26. Heritability was then partitioned across the 53 
genomic annotations provided with the package 27, with the addition of 5 annotations: 
open chromatin regions (ATAC and ATAC Bryois extend 500, which increases the 
window around the region by 500 bases in both directions), the intersection between 
ATAC and conserved regions of the genome (ATAC-conserved) and regions present 
in the Neanderthal genome (Neanderthal and Neanderthal extend 500 28, 29). 
Regions of open chromatin were identified in prefrontal cortical tissue from 135 
schizophrenic individuals and 137 controls using ATAC sequencing, which identifies 
stretches of DNA free of nucleosomes and other DNA-binding proteins 28, 30.  
 
Gene-wise analyses 
Results from the meta-analysis were filtered to retain only single nucleotide 
variants (SNPs) present in the European superpopulation of 1000 Genomes Phase 3 
31. SNPs were annotated to a gene using MAGMA v1.06, assigning SNPs to genes if 
they lay between 35kb upstream and 10kb downstream of the gene location (as 
supplied on the MAGMA website, build 37 32). Gene-wise p-values were obtained 
from MAGMA as the aggregate of the mean and smallest p-value across all SNPs 
annotated to the gene. MAGMA accounts for possible confounders such as gene 
size, gene density, linkage disequilibrium and minor allele count, with reduced type 1 
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error compared to alternative software 33. The threshold for genome-wide 
significance was defined as p = 2.65 x 10-6, the Bonferroni correction for the 18 839 
genes tested. Genes passing genome-wide significance were defined as coming 
from the same locus if their locations were within 50kb of each other, or if they lay 
within clumped loci from the single variant analysis. Significant genes were cross-
referenced to the intellectual disability (ID) gene list provided with RegionAnnotator. 
The significance of the observed overlap was quantified as a hypergeometric test in 
R 34, using as background 1 366 ID/DD genes in 18 839 autosomal genes. 
 
Tissue- and cell-specific gene expression 
Tissue-specific and cell-type specific proportions of gene expression were 
calculated following the method described in detail in the Supplementary Methods 
and in 16. Tissue expression data was drawn from the GTEx Consortium 18, and brain 
cell-type expression data was drawn from scRNAseq data from mouse brain (KI 
mouse superset) 16. For each gene with a 1:1 homolog between mouse and human 
(Supplementary Methods) in each cell-type (or tissue), an enrichment score was 
calculated by dividing the mean Unique Molecular Identifier (UMI) counts for all cells 
in the cell-type by the summed mean UMI counts across all tissues 16. Unique 
molecular identifier counts are an absolute count of transcripts (rather than a relative 
count), and so can be compared directly across cells 16. Differences in the number of 
cells assessed of each type does not considerably bias the score, because it is 
reflective of the average, rather than of the total expression.  
Associations between gene-wise p-values from the meta-analysis and cell-
type specific (or tissue-specific) gene expression were calculated using two 
methods, implemented in MAGMA 32 and in LD Score 26. In MAGMA, genes were 
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grouped into 40 equal bins by ranked enrichment score within the cell-type (0-2.5th 
centile, 2.5-5th centile, up to 97.5th-100th centile) plus an additional bin for genes not 
expressed in the cell-type. Bin membership was regressed on gene-wise association 
with intelligence in the meta-analysis (For these analyses, gene-wise association 
was defined as the mean p-value across all SNPs assigned to the gene.) In LD 
Score, the 10% of genes with the highest enrichment score within each cell-type 
were used as a gene set for partitioned heritability analysis. That is, variants were 
annotated to genes in the top 10% (as described above for performing gene-wise 
association analyses). Heritability enrichment of this partition was calculated (in LD 
Score) by dividing the proportion of common-variant heritability captured by the 
variants by the proportion of all SNPs included in the annotation 27. The significance 
of this enriched was determined by a block jackknife approach 27. Results were 
considered significant if the association p-values were smaller than the relevant 
Bonferroni threshold for both methods. Accordingly, in order for a cell-type to be 
declared significant, genes associated with intelligence must be enriched roughly 
linearly with bin membership (MAGMA analyses) and enriched in the top 10% 
compared to the whole distribution (LD Score). These two criteria mean that the 
observed enrichment has to be robust to the complexity of gene expression in the 
cell-type. 
Conditional cell-specific analyses were performed as a secondary analysis to 
test whether each enriched cell-type observed was independent of all others. Full 
details of the method implemented are provided in Skene et al., 2017. In brief, for 
each enriched cell-type in turn (the target cell-type), z-scores from gene-wise 
association analyses with intelligence were randomly resampled without 
replacement. The mean z-score within each expression-specificity decile of the 
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target cell-type was held constant, but the mean z-score of each specificity decile of 
other cell types was randomized. Empirical p-values were derived for each of the 
other cell-types, and this procedure was repeated 10 000 times. Expression in each 
of the other cell-types is considered to be associated with intelligence independently 
of expression in the target cell type if the observed p-value is lower than the 500th 
empirical p-value (i.e. 95% of the empirical distribution 16).  
 
Predicted tissue-specific gene expression 
Results from the variant-level meta-analysis were used to predict gene 
expression using MetaXcan and genomic and transcriptomic reference data from the 
brain regions assayed in the GTEx project 18, 35. Associations between predicted 
gene expression levels and intelligence were calculated. Significance was set at 
1.60x10-6, the Bonferroni correction for the 31303 gene-tissue pairs tested 35. 
Significant genes were cross-referenced to the intellectual disability gene list 
provided with RegionAnnotator.  
 
Pathway analysis 
A pathway matrix P was generated with elements Pg,p = 1 if gene g was in 
pathway p and Pg,p = 0 otherwise. The elements in the matrix were multiplied by 
binned gene expression weights obtained from GTEx data (as in the foregoing 
section on tissue-specific expression) for 13 brain regions and 32 tissues, generating 
45 weighted gene/pathway matrices. Only genes with expression data were taken 
into account. Association between these tissue-weighted pathways and gene-wise 
associations with intelligence was computed using MAGMA. 13 564 pathways were 
drawn from OpenTargets (downloaded January 2017 36), GO ontologies, canonical 
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pathways drawn from MSigSB v5.2 C2 and C5 datasets 37, and biological pathways 
related to psychiatric disorders found in various scientific publications (a link to each 
pathway source is provided in Supplementary Table 4). The pathways assessed by 
this approach are related to each other in a complex fashion; GO pathways are 
hierarchical and MSigDB and OpenTargets pathways capture related gene sets. 
Accordingly, in order to control for multiple testing, the effective number of pathways 
tested was established by computing the number of principal components 
accounting for 99.5% of explained variance in the pathway similarity matrix, obtained 
by computing the Tanimoto similarity between pathways. This results in a Bonferroni-
corrected threshold of p = 5.34x10-6 for 9 361 effectively independent tests for each 
matrix. A more stringent threshold was applied secondarily, taking into account all 
tissue-specific pathway matrices for a total for 9 361 x 46 tests and threshold p = 
1.16x10-7. 
 
Conditional gene set enrichment 
Gene sets of interest were drawn from the results of pathway analyses. 
Specifically, the human postsynaptic density proteome gene set 38 was used to 
capture the effects of synaptic and neuronal pathways. Gene sets of RBFOX and 
CELF4 targets were included as they showed enrichment that appears to be driven 
by brain-specificity, and have been previously implicated in other brain-related traits 
16, 39, 40. ID/DD gene sets were tested as they are of specific interest to the study of 
intelligence. To assess whether the enrichment of these gene sets is independent of 
gene expression in somatosensory pyramidal neurons, conditional analyses were 
performed following the method described above for conditional cell-type analyses, 










The genetic correlation between Sniekers et al. (2017) and HiQ was 0.92 (SE: 
0.07) and was sufficiently high to justify meta-analysis. 25 loci met genome-wide 
significance with intelligence (i.e., p < 5 x 10-8; Table 1, Figure 1a). Of these, 13 were 
genome-wide significant in Sniekers et al. (2017) and 12 were novel (Table 1; 
Supplementary Table 1). The single locus previously identified in the HiQ sample 
was not genome-wide significant in this analysis (p = 0.00595 17). 
Assessment of genome-wide inflation yielded a median λGC of 1.24. The LD 
score regression intercept was 1.004 (SE: 0.01). A λGC substantially greater than 1 
indicates genome-wide inflation, which can result from confounding factors such as 
population stratification and batch effects, or from real effects distributed across 
multiple variants (polygenicity). In contrast, an LD Score regression intercept greater 
than 1 is indicative of confounding only (as polygenicity contributes to the slope of 
the regression, not the intercept) 26. As such, these results taken together suggest 
that this inflation is caused by polygenicity rather than confounding (Figure 1b) 26. 
Annotation of specific genomic loci to databases of interest suggested 
overlapping loci between intelligence and a variety of phenotypes (Supplementary 
Table 2). The largest overlap was observed with educational attainment (14/25 loci), 
but overlap at multiple loci was widespread, including with age at menarche, height, 
body mass index, autoimmune disease, and schizophrenia. Genes previously 
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implicated in intellectual disability or developmental delay (ID/DD) were present 
within 9/25 loci.  
 
Heritability and partitioned heritability 
LD Score regression yielded a SNP-heritability estimate of 0.221 (SE: 0.01) in 
line with the previously reported SNP-heritability in Sniekers et al (2017). Partitioning 
this heritability across 58 functional SNP annotations identifies conserved regions as 
significantly enriched contributors to the heritability of intelligence (proportion of 
heritability = 0.340, enrichment = 13.3 fold, p = 3.26 x 10-8), consistent with previous 
reports in a subset of our meta-analyzed cohorts 41. Four extended annotations were 
also significantly enriched (p < 8.62 x 10-4; Figure 2), suggesting that genetic 
variation located in the vicinity of conserved regions, enhancers (specifically 
H3K4me1 elements) and open chromatin in brain dorsolateral prefrontal cortex 28 
and fetal cells) are enriched in heritability for intelligence. 
 
Gene-wise analyses 
93 genes at 41 loci were identified at genome-wide significance (p < 2.65 x 
10-6, Bonferroni threshold for 18 839 genes; Table 2, Supplementary Figure 1). 28 of 
these genes (20 loci) were also identified in Sniekers et al. (2017). 11 of the 93 
genes were previously implicated in intellectual disability or developmental delay, 
although this overlap does not significantly from what is expected under the null 
hypothesis of no enrichment (p = 0.073, hypergeometric test; Table 2). 
 
Tissue- and cell-specific gene expression 
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Tissue-specific enrichment analysis identified an enrichment of genes with 
high brain-specific expression associated with intelligence (pMAGMA = 4.43 x 10-9, 
pLDSC = 4.23 x 10-6; Figure 3a, Supplementary Table 3a). Across 10 brain regions in 
GTEx18, stronger gene associations with intelligence were associated with increased 
specificity of gene expression to the frontal cortex (pMAGMA = 0.00305, pLDSC = 2.66 x 
10-4; Figure 3b, Supplementary Table 3b). 
 In the KI level 1 (broad cell groups) cell-type specific analyses, both linear 
regression (MAGMA) 32 and heritability enrichment-based analyses (LD Score) 27 
supported enrichment of genes with high specificity to pyramidal neurons in the 
somatosensory neocortex (pMAGMA = 1.41 x 10-6, pLDSC = 5.81 x 10-4) and in the CA1 
region of the hippocampus (pMAGMA = 9.08 x 10-5, pLDSC = 1.12 x 10-3), as well as to 
midbrain embryonic GABAergic neurons (pMAGMA = 9.47 x 10-5, pLDSC = 1.61 x 10-3; 
Figure 3c, Supplementary Table 3c). Level 2 analyses (narrowly-defined cell types) 
suggested significant enrichment of genes with high specificity to type pyramidal 
cells of the CA1 region (pMAGMA = 2.16 x 10-4, pLDSC = 1.19 x 10-4), although 
considerable variability was observed between methods at this level of granularity 
(Figure 3d, Supplementary Table 3d). 
Cell-type specific analyses were repeated conditioning on each enriched cell-
type in turn. When controlling for gene expression in pyramidal neurons of the 
somatosensory neocortex, the previously observed enrichment in CA1 pyramidal 
cells is lost. In contrast, the patterns of enrichment observed when conditioning on 
expression in CA1 pyramidal cells or in midbrain embryonic GABAergic neurons 
were consistent with those observed without conditioning (Figure 4).  
 
Predicted tissue-specific gene expression 
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Across the 10 GTEx brain tissues, results from MetaXcan suggested 
significant effects on the expression of 16 genes (p < 1.60x10-6; Table 3). Eight of 
these genes are situated at locus 11 (Chr3, 48.7-50.2 Mb). Genetic variation was 
predicted to upregulate 6 genes and downregulate 10 genes, with both single-region 
(9 genes) and multiple-region (7 genes) patterns of altered expression implied. Three 
genes (NAGA, TUFM and GMPPB) have previously been implicated in ID.  
 
Tissue-specific pathway analysis 
Tissue-specific pathway analyses identified 32 nested pathways with p ≤ 
5.34x10-6 (Bonferroni correction for 9 361 effectively independent pathways), of 
which 29 contained genes that were significant in the gene-wise analysis 
(Supplementary Table 4; Supplementary Figure 2). 7 pathways remained significant 
after further correcting for all tissue-specific tests: "self-reported educational 
attainment", "modulation of synaptic transmission", "neurodegenerative disease", 
"neuron spine", "schizophrenia", "rare genetic neurological disorder", and "potentially 
synaptic genes" (Table 4).  
 
Conditional gene set enrichment 
Results from tissue-specific and gene-set analyses identified a number of 
gene sets associated with intelligence. Of specific interest were synaptic genes 
(post-synaptic density proteome list 37), RBFOX family binding partners 40, CELF4 
binding partners, and previously reported intellectual disability genes. Additional 
analyses were performed to assess whether the association of these gene sets was 
independent of the enrichment for gene expression in pyramidal cells of the 
somatosensory cortex. Bootstrapped analyses confirmed the association of each 
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gene set prior to conditional analysis (empirical p < 0.05; Supplementary Table 5). 
Conditioning on expression in gene expression in pyramidal cells of the 
somatosensory cortex, the enrichment for synaptic genes is no longer significant, 
indicating that this enrichment is not independent of that observed in the pyramidal 
neurons. This effect was not observed for RBFOX or CELF4 targets. Intellectual 
disability genes were weakly enriched prior to conditioning, and conditioning had little 
effect on enrichment. However, subdividing ID/DD genes into those associated with 
severe and those associated with moderate ID/DD indicated that the enrichment 
stemmed predominantly from moderate ID/DD genes, and this was not altered by 
conditioning on somatosensory pyramidal neuron gene expression (Supplementary 




 The overall power of our GWAS meta-analysis was equivalent to a sample 
size of ~99 000 individuals due to the inclusion of the extreme trait HiQ sample, 
which contributes equivalently to a population cohort of ~21 000 individuals, and is 
likely to be enriched for alleles associated with intelligence in the normal range. We 
mapped results from our GWAS to tissue and cell-type specific gene expression 
data, identifying enrichment of specificity at multiple levels: in the brain, the frontal 
cortex, midbrain embryonic GABAergic neurons and pyramidal neurons, especially 
those in the somatosensory cortex. A number of genes previously implicated in 
intellectual disability or developmental delay are predicted from the GWAS results to 
show differential gene expression for normal range IQ in different brain regions, and 




RNA sequencing data suggests that, as expected, genes more strongly 
associated with intelligence are enriched for brain-specific expression in general. 
While the dominance of brain-specificity over other body tissue specificity is 
pronounced, assessing differences within the brain is more difficult. Genes more 
strongly associated with intelligence showed higher specificity for frontal cortical 
expression, but the differences in cell composition between brain tissues means that 
cell-type analyses may be more informative. This can be seen within our results, in 
that pyramidal neurons of the somatosensory cortex were significant in the cell-type 
specific analysis, but the cortex as a whole is not significant in the GTEx brain-tissue 
analysis. This is perhaps due to the fact that the cortex is a highly heterogeneous 
mixture of cell-types. Our results suggest expression in pyramidal neurons in one 
area of the cortex is relevant in intelligence, but expression in the other cell-types 
and areas of the cortex may not be 42. A further caveat to this interpretation is that 
the full cellular composition of the cortex (and the brain overall) is not reflected in the 
KI mouse superset, and as such our conclusions about wider effects must be 
constrained.  
Genes with higher specificity to pyramidal neurons were enriched for 
associations with intelligence. However, the location of the most interesting neuron 
population is not yet clear. Observed enrichment in the pyramidal cells of the CA1 
region of the hippocampus was lost when accounting for gene expression in 
pyramidal cells of the somatosensory cortex. An uncaptured population of pyramidal 
neurons (for example, in the frontal cortex) may exist that similarly overlaps in 
expression with the somatosensory pyramidal neurons, and accounts for the 
enrichment observed in the latter population. While the KI superset is the largest 
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brain scRNAseq resource to date, it covers a limited set of regions and 
developmental stages 16. 
Tissue and cell-specific analyses were performed using related but distinct 
approaches, namely linear regression of binned specificity and heritability 
enrichment analysis of the top 10% of specific genes. Linear regression tended to 
give smaller p-values than heritability enrichment analysis (Supplementary Table 3). 
While this may be a statistical artefact generated by the differing assumptions of the 
methods, this could also result from the pattern of enrichment. For example, a small 
set of genes associated with intelligence, all with very high specificity to a given 
tissue would result in a lower p-value from heritability enrichment than if the 
association with intelligence was spread more broadly across genes with generally 
enriched tissue-specificity. 
Increased specificity of expression of genes associated with intelligence was 
identified across a number of cell-types and tissues. However, increased specificity 
of expression does not demonstrate a functional role for these genes in these cell-
types. Conversely genes with similar expression profiles between tissues might differ 
in their action in functionally-relevant ways. As such, our results are suggestive of 
cell-types and tissues of interest for further study, but are by no means a conclusive 
explanation of the biological action of intelligence-associated genes.  
The results of analyses in the KI mouse superset for intelligence can be 
contrasted with those for schizophrenia 16. Both phenotypes initially demonstrate 
enrichment for the same hippocampal and somatosensory pyramidal neuron 
populations. However, conditional analyses in schizophrenia demonstrated 
significant differences in the results between schizophrenia and intelligence - the 
enrichment observed in the somatosensory cortex in schizophrenia could be fully 
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explained by that in the hippocampus, while the opposite pattern was observed in 
intelligence. Additionally, unlike in schizophrenia, genes implicated in intelligence 
also showed specificity in midbrain embryonic cells. Analyses in schizophrenia 
implicated more level two cell types than were significant in our analyses. Such 
differences may reflect differences in the common-variant contribution to variance in 
intelligence and schizophrenia; despite a similar effective sample size to the 
schizophrenia GWAS (40 675 cases, 64 643 controls, Neff ~ 100K), this GWAS 
identified only 25 loci compared with the 140 associated with schizophrenia 43. This 
highlights that intelligence is potentially more polygenic than schizophrenia, despite 
similar estimates of heritability captured by common variants.  
There is not a direct link between heritability and the molecular genetics of a 
trait (beyond a non-zero heritability implying that overall genetic similarity is 
correlated with phenotypic variance). Heritability alone is not informative about the 
potential biological consequences of statistical associations, except in placing a limit 
on explanatory power. In this GWAS, common variants explained 22% of the 
variance in intelligence (and gene-wise associations will only capture a portion of 
that). A considerable proportion of variance in intelligence is not captured in our 
analyses, and therefore it should be noted that our conclusions drawn on only one 
part of the genetic and non-genetic correlates of this trait.  
The KI mouse superset has a number of strengths; it is the largest and 
broadest scRNAseq dataset to date, captures extra-nuclear as well as nuclear 
transcripts, and was generated using identical methods (Supplementary Note 16). 
However, there are also limitations to the use of this dataset. One issue is that the 
expression data used is derived from mice rather than humans. Gene expression in 
the brain is conserved across mammals, such that the principal axes of variation in 
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comparative studies of gene expression capture inter-tissue, rather than inter-
species, variance 44. Furthermore, there is a high degree of conservation of gene 
expression between mouse and human brains specifically 16, 45, 46. Previous analyses 
using the KI mouse superset have made extensive comparison between mouse and 
human gene expression and found high concordance in mapping mouse to human 
genes 16. Further discussion of the use of mouse-derived data, including references 
for data access, is included in the Supplementary Note and in 16. 
Nevertheless, cell types which are not enriched for genes associated with 
intelligence in this study should not be prematurely excluded, as some cell-types are 
not present in the dataset and others will have dissimilar functions or have been 
exposed to different evolutionary pressures in mouse and in human. Intelligence is a 
major characteristic that differentiates humans from other mammals 47. As such, it 
may be the case that genes with higher specificity to regions dissimilar between 
humans and mice could be enriched for associations with intelligence, which would 
not be captured by this approach.  
Our results highlight potential insights beyond those gleaned from tissue-
specific expression patterns. Several genes previously implicated in ID/DD were 
present in loci associated in the GWAS. An example of this is GMPPB (GDP-
Mannose Pyrophosphorylase B), which is in locus 11 of the GWAS results, and was 
genome-wide significant in gene-wise analyses. It is a member of the "rare genetic 
neurological disorder" gene set (significantly enriched, specifically in neural tissues), 
and the expression of GMPPB was predicted to be downregulated in the cortex of 
individuals with higher intelligence. Rare loss of function mutations in the GMPPB 
gene have been identified as causal mutations in tens of individuals with muscular 
dystrophies and myasthenias, many of which present with mild to severe ID 48–52. 
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The product of this gene is important for the glycosylation of a-DG (alpha-
dystroglycan - the dystroglycan gene DAG is also present in locus 11 and is a 
significantly associated gene in this analysis 48). Glycosylation is required for the 
interaction of a-DG with extracellular ligands, with a variety of consequences 
including the organization of axon guidance 53. Our results, in the context of the 
medical genetic literature, suggest the effects on axon guidance by glycosylated a-
DG may be an area worthy of further exploration to understand the biology of 
intelligence. Specifically, we might tentatively hypothesize that GMPPB acts via a 
gradated effect, in which too little or no expression of the gene causes intellectual 
disability, whereas an optimal amount may lead to higher intellectual ability, while too 
much results in a (mild) decrease in intellectual ability. This hypothesis would require 
neurobiological evidence to test. 
However, the observed overall overlap of all ID/DD genes with loci from the 
GWAS does not differ from that expected by chance. This lack of significant 
enrichment is partly reflected in the pathway analysis - there are several overlapping 
gene sets designed to capture ID/DD genes. Of these, only "rare genetic 
neurological disorder" was significantly enriched following correction. Further insight 
is obtained from conditional gene-set analyses - although the overall "intellectual 
disability" gene set is only nominally associated with intelligence, stratifying this gene 
set demonstrates considerable enrichment of mild intellectual disability genes, 
independent of gene expression in somatosensory pyramidal neurons. The presence 
of genes causative of ID/DD in loci associated with intelligence in the normal range, 
and the enrichment of specific pathways and gene sets derived from the ID/DD 
literature, may indicate shared biology between ID/DD and normal intelligence. 
However, the lack of broad enrichment of all such genes suggests that there may 
22 
 
also be distinct pathways contributing to normal intelligence that are not commonly 
affected in ID/DD. ID/DD is not a single condition, but a group of disorders with 
differing etiologies - our results are still consistent with a two-group model of ID/DD 
etiology 54–56. 
The meta-analysis results presented herein extend previous findings 4. The 
results are largely consistent with those previously reported, which is unsurprising. 
More genes were identified in our gene-wise analysis due to an analytical decision to 
extend the boundaries by which each gene is defined 35kb upstream and 10kb 
downstream of the coding region 57, 58. Defining genes using this boundary (as 
opposed to no boundary extension) captures additional transcriptional elements - 
these may be specific to the target gene, but may also capture elements with more 
distal regulatory effects. 
Deriving testable biological hypotheses from the statistical associations of 
GWAS results is one of the central challenges for the immediate future of complex 
genetics 3, 15. The provision of high-quality reference datasets encompassing genetic 
information from variation to translation, and the integration of genomic data to such 
reference data is invaluable to this aim 16, 18. We have demonstrated that some 
insights into the biology of intelligence can be derived from GWAS, and have 
suggested potential avenues for further exploration. Our results could indicate that 
intelligence represents optimal pyramidal neuron functioning. Cognitive tests are 
highly correlated with general intelligence (g), which may depend on pyramidal 
neuron function 7.  
Understanding how biology underlies variation in intelligence is an active area 
of research that is beginning to yield results. Unifying these new genetic results with 
data from multiple approaches, can increase the power of each approach, has the 
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potential to yield greater understanding of the biology of intelligence, which in turn 
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Figure Legends 
Figure 1: a) Manhattan plot and b) QQ plot of meta-analysis results. 
 
Figure 2: Heritability enrichment of genomic annotations (dots) +/- 1 standard error 
(bars). Horizontal line is p = 8.62x10-4, Bonferroni-corrected threshold for 58 
annotations. Vertical line is enrichment = 1 (that is, no enrichment).  
 
Figure 3: Results of tissue- and cell-specific analyses. a) Whole-body analyses; b) 
Brain tissue analyses; c) KI level 1 cell analyses; d) KI level 2 cell analyses (only 
those significant in MAGMA competitive analyses after correction for multiple testing 
shown). Vertical lines are the Bonferroni threshold for each analysis. Results shown 
are from MAGMA analyses - tissues and cell-types also significant in LDSC analyses 




Figure 4: Conditional cell-type enrichment analysis. X-axis lists target cell-types. Y-
axis lists other cell-types. Colors correspond to the enrichment probability of the 
other cell type after conditioning (P). Values of log(P) approaching zero indicate no 
enrichment after conditioning. Barplot on the right shows the minimum value of P for 
each cell-type across all conditional analyses (excluding analyses of the target cell-
type with itself); the vertical line marks p=0.05. Red box highlights the loss of 
significant enrichment in CA1 pyramidal neurons when conditioning on 
somatosensory (SS) neurons. 
